Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 295-995-3 | CAS number: 92201-64-4 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Eucalyptus radiata australiana, Myrtaceae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 23 March 2022 to 07 April 2022
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study performed according to OECD test guideline No. 471 and under compliance with GLP (GLP deviation: the homogeneity test on the test item was not supplied by the Sponsor. Without impact on the conclusion of the study).
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
- Report date:
- 2022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- Adopted July 21st, 1997 and corrected June 26th, 2020
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- QA statement signed on 2022-05-18
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Eucalyptus radiata australiana, ext.
- EC Number:
- 295-995-3
- EC Name:
- Eucalyptus radiata australiana, ext.
- Cas Number:
- 92201-64-4
- Molecular formula:
- Not applicable
- IUPAC Name:
- Essential oil of Eucalyptus radiata (Myrtaceae) obtained from leaves and twigs by steam distillation
- Test material form:
- liquid
- Details on test material:
- EC No: 295-995-3
CAS No: 92201-64-4
Color: colorless to pale yellow
1
Method
- Target gene:
- Histidine and tryptophan
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Details on mammalian cell type (if applicable):
- Strains of Salmonella typhimurium and Escherichia coli were purchased from MOLTOX (TM) and maintained in the laboratory (lyophilized discs stored at 2-8°C from TRINOVA BIOCHEM) according to internal SOP. The genotype of bacterial strains was checked for histidine and tryptophane requirements, loss of cell wall LPS (rfa mutation), ampicillin resistance, UVB and UVA sensitivity, spontaneous revertant rate and sensitivity to reference mutagens.
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9: S9 fraction, microsome fraction prepared from Sprague Dawley rat liver homogenate, was provided by MOLTOX (TM) (POB Box 1189 - 157 Industrial Park Dr - Boone, NC 28607 - USA) (S9 Moltox-11-101.5-4477 validated on 11.10.2021 – expiry date: 13.07.2023).
- method of preparation of S9 mix:
The final concentration of co-factors and salts was as follows:
S9 fraction: 10%
MgCl2-6H2O: 8 mM
KCl: 33 mM
Glucose-6-phosphate Na2: 5 mM
NADP Na2: 4 mM
Phosphate buffer (pH 7.4): 0.1 M - Test concentrations with justification for top dose:
- - Assay 1 (+/- S9): 5, 15, 50, 150, 500 and 1000 µg/plate in TA 98, TA 100, TA 1535, TA 1537 and WP2 (uvr A-)(pKM101) with S9 and without S9 under the direct plate incorporation method.
- Assay 2 (+/- S9): 5, 15, 50, 150, 500 and 1000 µg/plate in TA 98, TA 100, TA 1535, TA 1537 and WP2(uvr A-)(pKM101) without S9 and with S9 under the pre-incubation method. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Ethanol
- Justification for choice of solvent/vehicle: The test item is soluble in ethanol. A stock solution for each assay was prepared extemporaneously at 20 mg/mL in ethanol. The aspect of solution for assay n°1 and n°2 was a limpid colorless solution. Due to the toxicity, the highest dose tested was 1000 µg/plate.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-Anthramine
- Remarks:
- In the presence of S9-mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO (for 2-Nitrofluorene and 9-Aminoacridine) and NaCl 0.15 M (for Sodium Azide and Methyl methanesulfonate)
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- methylmethanesulfonate
- Remarks:
- In the absence of S9-mix
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS: 3 plates/dose for all groups
STERILITY TESTS
Test item and the corresponding dilutions were added to 2 mL of top agar maintained at 45°C and poured after homogenization on the bottom agar (20 ml) onto a Petri plate (90 mm in diameter) (n = 3). Plates were incubated for 48 - 72 hours at 37°C and then examined. There should be no bacterial growth on any plate. S9-mix sterility was checked using the same protocol.
PRELIMINARY CYTOTOXICITY TESTING (Strain TA 100)
In a test tube, 0.1 mL of the bacterial suspension (1-9 x 103 bacteria/mL) and 50 µL of the stock solution and dilutions, were successively added to 2 mL of top agar at 45°C, containing 10 % (v/v) of a solution of L-Histidine-D-Biotine (2.5 mM). After homogenization, the content of the tube was poured onto a Petri plate (90 mm in diameter) containing minimal agar (20 mL). 3 plates per concentration were incubated for 24-72 hours at 37°C, and the colonies counted. A negative control containing the blank alone was run in parallel.
In case bacteriostatic activity is detected, the highest concentration to be retained is that exhibiting a bacteriostatic activity of 75 % or less. The precipitate, if present, should not interfere with the scoring. The following four dilutions studied are distributed according to a semi-logarithmic progression.
METHOD OF TREATMENT/ EXPOSURE
- Assay without S9:
->Salmonella Typhimurium strains: for each strain, 0.1 mL of the bacterial suspension containing 1 9 x109 bacteria/mL and 50 µL of each dilution of the original solution and 0.5 mL of sterile phosphate buffer were successively added to 2 mL of overlay agar, maintained supercooled at 45° C, containing 10 % (v/v) of a L Histidine-D-Biotine solution (0.5 mM).
->Escherichia coli strain: in a test tube 0.1 mL of the bacterial suspension containing 1-9 x 109 bacteria/mL and 50 µL of each dilution of the original solution and 0.5 mL of phosphate buffer were successively added to 2 mL of overlay agar maintained super cooled in 45° C containing 5% (v/v) of nutrient broth n° 2 to which are added 5 µL of a L-Tryptophan solution at 2 mg/mL.
Plates were incubated at 37° C over a 48-72-hour period. The number of revertant colonies per plate was counted.
- Assay with S9:
Two methodologies were used:
* In assay 1, a standard plate incorporation method where the protocol is similar to that described above, except that, 500 µL of S9-mix fraction is quickly added, before pouring the mixture onto the plates;
* In assay 2, as the first assay is negative in presence of test item, the pre-incubation method where the solution of the test item solution with the test strain, and 500 µL of S9-mix fraction are preincubated with shaking for 30 min., at 37° C prior to mixing with the overlay agar and pouring onto the minimal agar plate.
This method is known to increase the detection sensitivity of a number of promutagens like alkaloïds, aliphatic N-Nitroso compounds (OECD n° 471).
Moreover the following controls were carried out:
- Negative controls :
* absolute negative control containing no test item corresponding to the spontaneous reversion rate,
* solvent used to solubilize positive controls : DMSO, NaCl 0.15 M
- Vehicle used to solubilize test item: Ethanol
- Positive control
DATA PRESENTATION
After a 48-72-hour incubation period at 37° C, revertant colonies were manually counted in each plate.
Data are presented as the number of revertant colonies (mean ± standard deviation) per plate.
The following ratio is calculated:
R=(Number of revertant colonies in the presence of the test item)/(Number of revertant colonies in the absence of the test item) - Rationale for test conditions:
- Tested up to cytoxicity concentration (1000 µg/plate).
- Evaluation criteria:
- The following validity criteria were checked to validate each experiment:
• the bacteriostatic activity of the highest concentration tested shall be equal to or less than 75 %,
• the spontaneous reversion rate of the absolute negative control shall comply with the historical values of the laboratory,
• In presence of the solvent the spontaneous reversion rate shall comply with the historical values of the absolute negative control of the laboratory.
• the mean number of revertant colonies obtained for each strain and the corresponding positive control, with and/or without metabolic activation shall comply with the historical values of the laboratory.
• Negative and positive values should not show significant difference with the historical values of the laboratory (± 2 standard deviations). - Statistics:
- Not reported
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- E. coli WP2 uvr A pKM 101
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 1000 µg/plate with and without S9 in first assay // At 1000 µg/plate without S9 and from 500 to 1000 µg/plate with S9 in second assay
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- From 500 to 1000 µg/plate with and without S9 in first assay // From 500 to 1000 µg/plate without S9 and from 150 to 1000 µg/plate with S9 in second assay
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 1000 µg/plate without S9 and from 500 to 1000 µg/plate with S9 in first assay // At 1000 µg/plate without S9 and from 150 to 1000 µg/plate with S9 in second assay
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 1000 µg/plate without S9 and from 500 to 1000 µg/plate with S9 in first assay // At 1000 µg/plate without S9 and from 150 to 1000 µg/plate with S9 in second assay
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 1000 µg/plate with and without S9
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- STERILITY CONTROLS
- Results show the absence of any bacterial growth in the presence of the various concentrations of the test item.
- Results show the absence of any bacterial growth in the presence of "S9-mix".
BACTERIOSTATIC ACTIVITY CONTROL
Results show toxicity in presence of the test item for the three highest doses in the assay 1 (1500, 2500 and 5000 µg/plate), and toxicity for the highest dose in the assays 2 and 3 (1000 µg/plate). Therefore, the test item was tested at the following doses: 1 000, 500, 150, 50, 15 and 5 µg/plate.
MUTATION ASSAY INTERPRETATION
- There is no difference between the number of spontaneous reversions, the number of reversions obtained for the positive controls (without and with metabolic activation), and the mean of corresponding experimental historical values obtained in the laboratory.
- The numbers of revertant colonies in all cases did not exceed the criteria for a positive response and do not induce any mutagenic change in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA strains and Escherichia coli WP2(uvrA¯) (pKM 101) strain without or with metabolic activation in the presence of the dose range from 5 to 1000 µg/plate.
- According to the toxicity measured in the bacteriostatic assay we can observe a light to high thinning of the bacterial lawn observed in presence of the highest doses tested in presence and in absence of metabolic activation.
- Results are confirmed in an independent assay.
HISTORICAL CONTROL DATA
- Positive and negative controls showed absolute numbers of revertant colonies comparable to historical data of the test facility.
Applicant's summary and conclusion
- Conclusions:
- In the assay conditions, in presence of doses from 5 to 1000 µg/plate prepared from the test item EUCALYPTUS RADIATA OIL BATCH 406007, there is no evidence of any increase in the number of revertant colonies. Therefore, the test item does not induce any mutagenic change in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA 100 strains and Escherichia coli WP2(uvr A¯)(pKM101) strain with or without metabolic activation, according to the OECD Guideline n° 471.
- Executive summary:
In a reverse gene mutation assay performed according to the OECD test guideline No. 471 and in compliance with GLP, solutions obtained from EUCALYPTUS RADIATA OIL BATCH 406007 (Identification code: PH-22/0140) have been tested for their capacity to induce reverse mutation in four Salmonella typhimurium strains and one Escherichia coli WP2(uvr A¯)(pKM101) strain. This study was performed in the absence and presence of metabolic activation. To determine the dose-range concentrations, a preliminary cytotoxicity testing was performed and showed toxicity in presence of the test item for the three highest doses in the assay 1 (1500, 2500 and 5000 µg/plate), and toxicity for the highest dose in the assays 2 and 3 (1000 µg/plate). Therefore, two independent assays were carried out at the following doses: 1 000, 500, 150, 50, 15 and 5 µg/plate.
For assay n° 1, dose range from 5 to 1000 µg/plate was put in contact with the strains in the absence and presence of a metabolic activation system (S9-mix 10% (v/v)).
For assay n° 2, similar dose range was put in contact with the strains in the absence of metabolic activation and with pre-incubation in the presence of metabolic activation system (S9-mix 10% (v/v)).
For the two assays, negative and positive controls were carried out in parallel. Positive controls induced a significant increase in the number of revertant colonies compared to negative controls. There is no difference between the number of spontaneous reversions, the number of reversions obtained in the positive controls (without and with metabolic activation), and the mean of corresponding experimental “historical” values obtained in the laboratory. These results validate the two assays.
Evidence of toxicity, demonstrated by a light to high thinning of the bacterial lawn of non-revertant bacteria was observed in presence of the highest doses tested in presence and in absence of metabolic activation, in both the plate incorporation and the pre-incubation method.
The numbers of revertant colonies in all cases did not exceed the criteria for a positive response and do not induce any mutagenic change in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA strains and Escherichia coli WP2(uvrA¯)(pKM 101) strain without or with metabolic activation in the presence of the dose range from 5 to 1000 µg/plate.
In the assay conditions, in presence of dose range from 5 to 1000 µg/plate prepared from the test item EUCALYPTUS RADIATA OIL BATCH 406007 (Identification code: PH-22/0140), there is no evidence of any increase in the number of revertant colonies. Therefore, the test item does not induce any mutagenic change in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA 100 strains and Escherichia coli WP2(uvr A¯)(pKM101) strain with or without metabolic activation, according to the OECD Guideline n° 471.
Therefore, the test material is not mutagenic in the presence and absence of metabolic activation in Salmonella typhimurium TA 1535, TA 1537, TA 98 and TA 100 and Escherichia coli WP2 (uvrA-)(pKM101) strains. This study is considered as acceptable and satisfies the requirement for reverse gene mutation endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.